ForsetiMed SRL
ForsetiMed reported total assets of 435,240 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Aug 2026).
By total assets for 2025, ForsetiMed ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ForsetiMed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +289 % Total assets +183 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ForsetiMed's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
ForsetiMed's financial analysis
- Solvency93.6%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ForsetiMed
ForsetiMed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0781.636.688
- VAT number
- BE0781636688
- Peppol
- Registered · 0208:0781636688 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Feb 2022
- Registered office
- 1080 Molenbeek-Saint-Jean
- Latest accounts
- 2025 · filed on 07 Aug 2026
- Activity
- General medical practice activities (NACE 86210)
ForsetiMed (SRL) has been based in Molenbeek-Saint-Jean since 2022, active in: general medical practice activities. For 2025, it reports a net profit of 85,299 € and equity of 407,479 €; its revenue is not published. Its solvency stands at 93.6%, above the median of its sector (69.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ForsetiMed
Companies in the same business, of comparable size and area, outside its group.
- Docteur RAAD General medical practice activities Anderlecht · balance sheet 436,235 €
- Radiand General medical practice activities Grimbergen · balance sheet 429,987 €
- Medicor General medical practice activities Jette · balance sheet 734,477 €
- Medicama General medical practice activities Saint-Ghislain · balance sheet 435,640 €
- Dr. Beirinckx General medical practice activities Balen · balance sheet 436,571 €
- Medisch Kabinet Dr. Verlinden Georgina General medical practice activities Ternat · balance sheet 437,261 €
- Fongho Medical General medical practice activities Mons · balance sheet 329,119 €
- Dr. Guy Lyssens General medical practice activities Schilde · balance sheet 435,209 €
Frequently asked questions about ForsetiMed
What is the revenue of ForsetiMed?
ForsetiMed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ForsetiMed?
In Belgium, the VAT number is the company number prefixed with BE: BE0781636688 for ForsetiMed, if the company is VAT-registered. Its company number (CBE) is 0781.636.688.
Where is the registered office of ForsetiMed?
According to the CBE register, the registered office of ForsetiMed is in 1080 Molenbeek-Saint-Jean.
What is the equity of ForsetiMed?
At the close of the 2025 financial year, the equity of ForsetiMed amounts to 407,479 €, a solvency of 93.6% of total assets.
Who manages ForsetiMed?
The register lists 2 active mandates at ForsetiMed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ForsetiMed within its sector?
By total assets for 2025, ForsetiMed ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.
The full file of ForsetiMed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →